CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China.

CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China.
复制标题

重症新型冠状病毒病(COVID-19)的CT表现:中国黑龙江省病例报告

DOI:
10.1515/med-2020-0151
复制
发表时间:
2020
期刊:
Open medicine (Warsaw, Poland)
影响因子:
--
通讯作者:
Yi R
Yi R
中科院分区:
其他
文献类型:
--
作者:
Wang Z;Jiang H;Jiang H;Zheng R;Yi R

文献摘要

相似文献

摘要 2019新型冠状病毒病(COVID-19,以前称为新型冠状病毒肺炎)于2019年12月首次发现,并于2020年在中国和世界各地广泛传播。大多数患者的首发症状包括发烧、咳嗽和疲劳。随着病情进展可出现呼吸困难,严重者可出现急性呼吸窘迫综合征。本病CT表现主要为肺部毛玻璃样影(GGO),可伴有斑片状实变,疾病后期肺部可出现纤维性改变。结合典型的临床和影像学表现以及核酸检测结果阳性即可诊断该病。我们报告了中国黑龙江省首例新型冠状病毒病(COVID-19)病例。该患者病情严重,感觉发热、乏力、咳嗽、咳痰就诊,有武汉接触史。白细胞计数正常,淋巴细胞计数减少。 CT 成像显示双肺有大的 GGO 和部分斑片状实变。治疗26天后,患者康复出院。本研究通过掌握新型冠状病毒病(COVID-19)的典型影像学特征,有助于早期诊断和及时临床治疗。
Abstract 2019 novel coronavirus disease (COVID-19, previously known as novel coronavirus pneumonia) was first discovered in December 2019 and spread widely in China and all over the world in 2020. The initial symptoms of most patients include fever, cough, and fatigue. Dyspnea may occur with the progress of the disease, and acute respiratory distress syndrome may occur in severe cases. The CT manifestations of this disease are mainly ground-glass opacity (GGO) in the lung, which may be accompanied by patchy consolidation, and fibrous changes may appear in the lung at the later stage of the disease. Combined with typical clinical and imaging findings and positive nucleic acid test results, the disease can be diagnosed. We report the first case of novel coronavirus disease (COVID-19) in Heilongjiang Province, China. The patient was seriously ill, who felt that he suffered from fever, fatigue, cough, and expectoration and sought medical treatment, with a history of contact with Wuhan. The leukocyte count was normal, and the lymphocyte count was decreased. CT imaging showed large GGO and partial patchy consolidation in both lungs. The patient recovered and was discharged after 26 days of treatment. This study is helpful for early diagnosis and timely clinical management by mastering the typical imaging of novel coronavirus disease (COVID-19).